MicroRNA-26a/b regulate DNA replication licensing, tumorigenesis, and prognosis by targeting CDC6 in lung cancer

Molecular Cancer Research

Volumn 12, Issue 11, 2014, Pages 1535-1546

  Zhang, Xin ^a   Xiao, Dakai ^a   Wang, Ziyi ^b,c   Zou, Yongxin ^b,c   Huang, Liyan ^a   Lin, Weixuan ^a   Deng, Qiuhua ^a   Pan, Hui ^a   Zhou, Jiangfen ^a   Liang, Chun ^b,c   He, Jianxing ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN 6; MICRORNA; MICRORNA 26A; MICRORNA 26B; UNCLASSIFIED DRUG; CDC6 PROTEIN, HUMAN; CELL CYCLE PROTEIN; MESSENGER RNA; MIRN26A MICRORNA, HUMAN; NUCLEAR PROTEIN;

ADULT; ARTICLE; BINDING SITE; CANCER CELL; CANCER PROGNOSIS; CANCER STAGING; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SYNCHRONIZATION; COMPARATIVE STUDY; DNA REPLICATION; DNA REPLICATION LICENSING; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSIENT TRANSFECTION; TUMOR INVASION; UPREGULATION; AGED; CELL CYCLE; CELL MOTION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; LUNG TUMOR; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

AGED; BASE SEQUENCE; CARCINOGENESIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA REPLICATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; PROGNOSIS; RNA, MESSENGER; TUMOR STEM CELL ASSAY; UP-REGULATION;

EID: 84910643908     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-13-0641     Document Type: Article

References (40)

1. Karakaidos P, Taraviras S, Vassiliou LV, Zacharatos P, Kastrinakis NG, Kougiou D, et al. Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability-evidence of E2F-1 transcriptional control over hCdt1. Am J Pathol 2004;165:1351-65.
2. Ishimi Y, Okayasu I, Kato C, Kwon HJ, Kimura H, Yamada K, et al. Enhanced expression of Mcm proteins in cancer cells derived from uterine cervix. Eur J Biochem 2003;270:1089-101.
3. Li JN, Feng CJ, Lu YJ, Li HJ, Tu Z, Liao GQ, et al. mRNA expression of the DNA replication-initiation proteins in epithelial dysplasia and squamous cell carcinoma of the tongue.BMCCancer 2008;8:395.
4. Stoeber K, Tlsty TD, Happerfield L, Thomas GA, Romanov S, Bobrow L, et al. DNA replication licensing and human cell proliferation. J Cell Sci 2001;114:2027-41.
5. Todorov IT, Werness BA, Wang HQ, Buddharaju LN, Todorova PD, Slocum HK, et al. HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues. Lab Invest 1998;78:73-8.
6. Williams RS, Shohet RV, Stillman B. A human protein related to yeast Cdc6p. Proc Natl Acad Sci U S A 1997;94:142-7.
7. Williams GH, Romanowski P, Morris L, Madine M, Mills AD, Stoeber K, et al. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci U S A 1998;95:14932-7.
8. MendezJ,StillmanB.Perpetuatingthedoublehelix:molecularmachines at eukaryotic DNA replication origins. Bioessays 2003;25:1158-67.
9. Nishitani H, Lygerou Z. DNA replication licensing. Front Biosci 2004;9:2115-32.
10. Sclafani RA, Holzen TM. Cell cycle regulation of DNA replication. Annu Rev Genet 2007;41:237-80.
11. Zhai Y, Yung PYK, Liang C. Cell cycle control of DNA replication by phosphorylation and dephosphorylation of replication-initiation proteins in budding yeast. In: Ku-si-c-Ti-sma J, editor. Fundamental aspects of DNA replication. Croatia: InTech; 2011. p. 87-106.
12. Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS, et al. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev 1998;12:2120-30.
13. Ohtani K, Tsujimoto A, Ikeda M, Nakamura M. Regulation of cell growth-dependent expression of mammalian CDC6 gene by the cell cycle transcription factor E2F. Oncogene 1998;17:1777-85.
14. Yan Z, DeGregori J, Shohet R, Leone G, Stillman B, Nevins JR, et al. Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci U S A 1998;95:3603-8.
15. Farazi TA, Hoell JI, Morozov P, Tuschl T. MicroRNAs in human cancer. Adv Exp Med Biol 2013;774:1-20.
16. Ji Y, He Y, Liu L, Zhong X. MiRNA-26b regulates the expression of cyclooxygenase-2 in desferrioxamine-treated CNE cells. FEBS Lett 2010;584:961-7.
17. Zhang B, Liu XX, He JR, Zhou CX, Guo M, He M, et al. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis 2011;32:2-9.
18. Liu XX, Li XJ, Zhang B, Liang YJ, Zhou CX, Cao DX, et al. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett 2011;585:1363-7.
19. Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, et al. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009;361:1437-47.
20. Rahbari R, Holloway AK, He M, Khanafshar E, Clark OH, Kebebew E. Identification of differentially expressed microRNA in parathyroid tumors. Ann Surg Oncol 2011;18:1158-65.
21. Ciarapica R, Russo G, Verginelli F, Raimondi L, Donfrancesco A, Rota R, et al. Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma. Cell Cycle 2009;8:172-5.
22. Solomides CC, Evans BJ, Navenot JM, Vadigepalli R, Peiper SC, Wang ZX. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis. Acta Cytol 2012;56:645-54.
23. Zhu Y, Lu Y, Zhang Q, Liu JJ, Li TJ, Yang JR, et al. MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein. Nucleic Acids Res 2012;40:4615-25.
24. Li J, Kong X, Zhang J, Luo Q, Li X, Fang L. MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer. Cancer Cell Int 2013;13:7.
25. Feng D, Tu Z, Wu W, Liang C. Inhibiting the expression of DNA replication-initiation proteins induces apoptosis in human cancer cells. Cancer Res 2003;63:7356-64.
26. Duursma A, Agami R. p53-dependent regulation of Cdc6 protein stability controls cellular proliferation. Mol Cell Biol 2005;25:6937-47.
27. Hall JR, Kow E, Nevis KR, Lu CK, Luce KS, Zhong Q, et al. Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage. Mol Biol Cell 2007;18:3340-50.
28. Fernandez-Morales B, Pavon L, Cales C. CDC6 expression is regulated by lineage-specific transcription factor GATA1. Cell Cycle 2012;11:3055-66.
29. Wu Z, Cho H, Hampton GM, Theodorescu D. Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis. Neoplasia 2009;11:66-76.
30. Zhang K, Sha J, Harter ML. Activation of Cdc6 by MyoD is associated with the expansion of quiescent myogenic satellite cells. J Cell Biol 2010;188:39-48.
31. Akman BH, Can T, Erson-Bensan AE. Estrogen-induced upregulation and 30-UTR shortening of CDC6. Nucleic Acids Res 2012;40: 10679-88.
32. Sideridou M, Zakopoulou R, Evangelou K, Liontos M, Kotsinas A, Rampakakis E, et al. Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins. J Cell Biol 2011;195: 1123-40.
33. Gonzalez S, Klatt P, Delgado S, Conde E, Lopez-Rios F, Sanchez-Cespedes M, et al. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 2006;440:702-6.
34. Majid S, Dar AA, Saini S, Chen Y, Shahryari V, Liu J, et al. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res 2010;70:2809-18.
35. Lu J, He ML, Wang L, Chen Y, Liu X, Dong Q, et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res 2011;71:225-33.
36. Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, et al. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood 2008;112:4202-12.
37. Dang X, Ma A, Yang L, Hu H, Zhu B, Shang D, et al. MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells. Cancer Genet 2012;205:113-23.
38. Yang X, Liang L, Zhang XF, Jia HL, Qin Y, Zhu XC, et al. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology 2013;58:158-70.
39. Lv M, Zhang X, Li M, Chen Q, Ye M, Liang W, et al. miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma. PLoS One 2013;8:e67591.
40. Cai ZG, Zhang SM, Zhang H, Zhou YY, Wu HB, Xu XP. Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line. Cell Biol Int 2013;37:669-74.